Gabrail Cancer Center

Ohio City, Ohio 44718

1 studies enrolling now · 2 studies all time

What they study most

Advanced Refractory Solid Tumors, Advanced Solid Tumors, Non-Small Cell Lung Cancer, Subjects Considered Likely to Respond to CB-03-10

Studies at this site

• A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer — Recruiting now
• Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors — Status unconfirmed